353 related articles for article (PubMed ID: 3862732)
1. Apolipoprotein changes associated with the plasma lipid-regulating activity of gemfibrozil in cholesterol-fed rats.
Krause BR; Newton RS
J Lipid Res; 1985 Aug; 26(8):940-9. PubMed ID: 3862732
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of gemfibrozil on lipoprotein metabolism.
Saku K; Gartside PS; Hynd BA; Kashyap ML
J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipoprotein composition in alcoholic hepatitis: accumulation of apolipoprotein E-rich high density lipoprotein and preferential reappearance of "light'-HDL during partial recovery.
Weidman SW; Ragland JB; Sabesin SM
J Lipid Res; 1982 May; 23(4):556-69. PubMed ID: 7097121
[TBL] [Abstract][Full Text] [Related]
4. A single high-cholesterol, high-fat meal preferentially increases low molecular weight apolipoprotein B concentration in rat plasma.
DeLamatre JG; Krause BR; Wong L; Hoffmeier CA; Roheim PS
J Lipid Res; 1985 Aug; 26(8):924-9. PubMed ID: 4045320
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, modification, and flotation properties of rat hepatocyte apolipoproteins.
Hussain MM; Zanni EE; Kelly M; Zannis VI
Biochim Biophys Acta; 1989 Jan; 1001(1):90-101. PubMed ID: 2912498
[TBL] [Abstract][Full Text] [Related]
6. Effect of gemfibrozil on lipids, apoproteins, and postheparin lipolytic activities in normolipidemic subjects.
Gnasso A; Lehner B; Haberbosch W; Leiss O; von Bergmann K; Augustin J
Metabolism; 1986 May; 35(5):387-93. PubMed ID: 3458020
[TBL] [Abstract][Full Text] [Related]
7. Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.
Samuelsson O; Attman PO; Knight-Gibson C; Kron B; Larsson R; Mulec H; Weiss L; Alaupovic P
Nephron; 1997; 75(3):286-94. PubMed ID: 9069450
[TBL] [Abstract][Full Text] [Related]
8. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
[TBL] [Abstract][Full Text] [Related]
9. Effects of high cholesterol diets on rat plasma lipoproteins and lipoprotein-cell interactions.
Cole TG; Kuisk I; Patsch W; Schonfeld G
J Lipid Res; 1984 Jun; 25(6):593-603. PubMed ID: 6431045
[TBL] [Abstract][Full Text] [Related]
10. Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia.
Sirtori CR; Franceschini G; Gianfranceschi G; Sirtori M; Montanari G; Tremoli E; Maderna P; Colli S; Zoppi F
J Lab Clin Med; 1987 Sep; 110(3):279-86. PubMed ID: 3475394
[TBL] [Abstract][Full Text] [Related]
11. The effect of chronic cholesterol feeding on intestinal lipoproteins in the rat.
Riley JW; Glickman RM; Green PH; Tall AR
J Lipid Res; 1980 Sep; 21(7):942-52. PubMed ID: 7441062
[TBL] [Abstract][Full Text] [Related]
12. Gemfibrozil increases both apo A-I and apo E concentrations. Comparison to other lipid regulators in cholesterol-fed rats.
Krause BR; Newton RS
Atherosclerosis; 1986 Jan; 59(1):95-8. PubMed ID: 3081014
[TBL] [Abstract][Full Text] [Related]
13. Influence of gemfibrozil on high-density lipoproteins.
Glueck C
Am J Cardiol; 1983 Aug; 52(4):31B-34B. PubMed ID: 6577782
[TBL] [Abstract][Full Text] [Related]
14. Influence of dietary lipids on hepatic mRNA levels of proteins regulating plasma lipoproteins in baboons with high and low levels of large high density lipoproteins.
Kushwaha RS; McMahan CA; Mott GE; Carey KD; Reardon CA; Getz GS; McGill HC
J Lipid Res; 1991 Dec; 32(12):1929-40. PubMed ID: 1687745
[TBL] [Abstract][Full Text] [Related]
15. Dietary supplementation with Pluronic L-81 modifies hepatic secretion of very low density lipoproteins in the rat.
Manowitz NR; Tso P; Drake DS; Frase S; Sabesin SM
J Lipid Res; 1986 Feb; 27(2):196-207. PubMed ID: 3958622
[TBL] [Abstract][Full Text] [Related]
16. Lipid-regulating action of gemfibrozil in the stroke-prone spontaneously hypertensive rat.
Ogawa H; Tasaka M
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S313-5. PubMed ID: 9072407
[TBL] [Abstract][Full Text] [Related]
17. Effects of stigmastanyl-phosphocholine (Ro 16-6532) and lovastatin on lipid and lipoprotein levels and lipoprotein metabolism in the hamster on different diets.
Himber J; Missano B; Rudling M; Hennes U; Kempen HJ
J Lipid Res; 1995 Jul; 36(7):1567-85. PubMed ID: 7595080
[TBL] [Abstract][Full Text] [Related]
18. Effect of lipid transfer protein on plasma lipids, apolipoproteins and metabolism of high-density lipoprotein cholesteryl ester in the rat.
Groener JE; van Gent T; van Tol A
Biochim Biophys Acta; 1989 Mar; 1002(1):93-100. PubMed ID: 2493808
[TBL] [Abstract][Full Text] [Related]
19. Effects of fenofibrate, gemfibrozil and nicotinic acid on plasma lipoprotein levels in normal and hyperlipidemic mice. A proposed model for drug screening.
Olivier P; Plancke MO; Marzin D; Clavey V; Sauzieres J; Fruchart JC
Atherosclerosis; 1988 Mar; 70(1-2):107-14. PubMed ID: 3162679
[TBL] [Abstract][Full Text] [Related]
20. Effect of gemfibrozil on serum lipids in man.
Fenderson RW; Deutsch S; Menachemi E; Chin B; Samuel P
Angiology; 1982 Sep; 33(9):581-93. PubMed ID: 6751166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
